Abstract
To determine whether developmental hypothyroidism causes permanent disruption of neuronal development, we first performed a global gene expression profiling study targeting hippocampal CA1 neurons in male rats at the end of maternal exposure to anti-thyroid agents on weaning (postnatal day 20). As a result, genes associated with nervous system development, zinc ion binding, apoptosis and cell adhesion were commonly up- or down-regulated. Genes related to calcium ion binding were up-regulated and those for myelination were often down-regulated. We, then, examined immunohistochemical cellular distribution of Ephrin type A receptor 5 (EphA5) and Tachykinin receptor (Tacr)-3, those selected based on the gene expression profiles, in the hippocampal formation at the adult stage (11-week-old) as well as at the end of exposure. At weaning, both EphA5- and Tacr3-immunoreactive cells with strong intensities appeared in the pyramidal cell layer or stratum oriens of the hippocampal CA1 region. Although the magnitude of the change was decreased at the adult stage, Tacr3 in the CA1 region showed a sustained increase in expressing cells until the adult stage after developmental hypothyroidism. On the other hand, EphA5-expressing cells did not...Continue Reading
References
May 1, 1991·Neurotoxicology and Teratology·M AkaikeT Kobayashi
Mar 30, 1982·Toxicology and Applied Pharmacology·C P Comer, S Norton
Jun 11, 1999·Neuroscience·D MileusnicS A Lorens
Jun 22, 1999·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·G Olivieri, G C Miescher
Mar 4, 2000·Laboratory Investigation; a Journal of Technical Methods and Pathology·M ShibutaniM Hirose
Aug 20, 2002·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·Chikako UneyamaMasao Hirose
Apr 3, 2003·The Journal of Clinical Investigation·Rosalía Lavado-AutricGabriella Morreale de Escobar
Oct 29, 2003·Toxicology·Naoya MasutomiMasao Hirose
Jul 17, 2004·Endocrinology·Christopher M SchoonoverGrant W Anderson
Aug 4, 2005·Molecular Pharmacology·Bénédicte Salthun-LassallePatrick P Michel
Nov 11, 2005·Journal of Neuroendocrinology·A Oh-NishiN Suzuki
Feb 1, 2006·Molecular Psychiatry·A Montero-PedrazuelaA Guadaño-Ferraz
Feb 28, 2006·Analytical Biochemistry·Kyoung-Youl LeeMasao Hirose
Feb 24, 2007·Endocrinology·Jeffrey H Goodman, Mary E Gilbert
Apr 20, 2007·Developmental Neurobiology·Makoto ShibutaniMasao Hirose
Aug 24, 2007·Neuroscience Letters·Yohtaro NumachiToru Nishikawa
Nov 13, 2007·International Immunopharmacology·Ryosuke NakamuraJun-Ichi Sawada
Mar 11, 2008·Public Health Nutrition·Gabriella Morreale de EscobarFrancisco Escobar del Rey
Jan 29, 2008·Recent Patents on CNS Drug Discovery·Paul W Smith, Lee A Dawson
Oct 22, 2008·European Journal of Pharmacology·Rebecca E NordquistWill Spooren
Dec 20, 2008·Journal of Neuroendocrinology·J E RoylandM E Gilbert
Jan 7, 2009·Brain Research·Kumiko KobayashiRyozo Tsuji
Mar 21, 2009·Cancer Science·Gye-Hyeong WooMakoto Shibutani
Mar 28, 2009·The Journal of Comparative Neurology·Margaret A CooperRenping Zhou
Apr 29, 2009·Reproductive Toxicology·Makoto ShibutaniAkiyoshi Nishikawa
Citations
Mar 15, 2012·Archives of Toxicology·Yukie SaegusaMakoto Shibutani
Apr 17, 2012·Reproductive Toxicology·Hitoshi FujimotoMakoto Shibutani
Jun 4, 2014·Journal of Neuroendocrinology·M E GilbertJ H Goodman
May 15, 2013·The Journal of Toxicological Sciences·Hirotoshi AkaneMakoto Shibutani
Aug 6, 2013·Journal of Toxicologic Pathology·Hitoshi FujimotoMakoto Shibutani
Mar 20, 2020·American Journal of Physical Anthropology·Eduardo Fernandez-DuqueAnthony Di Fiore
Apr 11, 2018·Parasite : Journal De La Société Française De Parasitologie·Melissa J WalkerDanny Haelewaters
Sep 15, 2020·ACS Chemical Neuroscience·Wen-Wen ZhangYu-Xia Chu